This inventor holds 6 USPTO granted patents and 8 published patent applications and 5 EPO patents. Top assignees: Mayo Foundation for Medical Education and Research, Osaka University. Active years: 2016-2025.
Company Filing History:
6 out of 1,808 
1 out of 1,041 
Years Active: 2016-2025
Title: Thomas R. Caulfield - Innovator in Cancer Treatment
Introduction
Thomas R. Caulfield, based in Jacksonville, FL, is a distinguished inventor with a groundbreaking focus on cancer treatment. With a total of six patents to his name, his work significantly contributes to medical advancements and offers hope in the fight against various forms of cancer.
Latest Patents
Among his notable innovations are two complementary patents centered on compounds and methods for treating cancer. The first patent outlines compositions and methodologies for targeting renal cancers, including renal cell carcinoma, as well as addressing a wide array of other cancers such as ovarian, breast, prostate, colon, pancreatic, bladder, liver, lung, and thyroid cancers. This innovative approach involves the use of inhibitors of stearoyl-Coenzyme A desaturase 1 (SCD1) to enhance treatment efficacy for these cancers. The second patent similarly focuses on utilizing SCD1 inhibitors in conjunction with checkpoint inhibitors to improve therapeutic outcomes across multiple cancer types.
Career Highlights
Throughout his career, Thomas R. Caulfield has been affiliated with esteemed institutions such as the Mayo Foundation for Medical Education and Research and Osaka University. His work in these organizations has enhanced cancer research and fostered an environment conducive to innovative medical therapies.
Collaborations
In the pursuit of his innovative research, Caulfield has collaborated with significant figures in the field, including Han W. Tun and John A. Copland, III. These partnerships have enriched his work and facilitated groundbreaking advancements in cancer treatment methodologies.
Conclusion
Thomas R. Caulfield's contributions to the field of cancer treatment through his inventive patents reflect his dedication to improving patient outcomes. His pioneering research holds the promise of advancing therapeutic strategies that could transform the landscape of cancer treatment. As he continues to innovate, the medical community eagerly anticipates the impact of his work on future therapies.